Nitrendipin Aristo (Nitrendipine)

Nitrendipine, the active ingredient in Nitrendipin Aristo, is a calcium channel blocker presented as an oral formulation for oral use. It selectively relaxes vascular smooth muscle, thereby lowering blood pressure and relieving myocardial oxygen demand in adults with essential hypertension or chronic stable angina.

GNH USA supplies Nitrendipin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU regulatory standards for prescription‑only medicines and ensuring quality control, proper packaging, and timely delivery to meet global healthcare needs.

Nitrendipine is used to treat cardiovascular conditions that involve elevated arterial pressure or myocardial oxygen demand.

Essential hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. Chronic stable angina: improves exercise tolerance by decreasing cardiac workload and oxygen consumption. Co‑existing coronary artery disease: provides additional blood‑pressure control while alleviating anginal symptoms.

Nitrendipine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Flushing - Peripheral edema - Dizziness or light‑headedness - Tachycardia - Nausea

Serious or Rare Side Effects: - Severe hypotension - Myocardial infarction - Cardiac arrhythmias - Hepatic dysfunction - Allergic reactions including rash or urticaria - Stevens‑Johnson syndrome (very rare)

Before initiating therapy, clinicians should consider several safety aspects.

Blood pressure monitoring: check baseline and periodic readings before and during treatment. Cardiovascular status: avoid abrupt discontinuation in patients with established coronary artery disease. Concomitant vasodilators: use caution when combined with other agents that lower vascular tone. Liver function: assess hepatic status in patients with known liver impairment. Pregnancy and lactation: prescribe only if potential benefits outweigh potential risks. Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Nitrendipine can interact with several drug classes, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Combined use with other potent vasodilators (e.g., nitroglycerin): risk of severe hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma concentrations. - Grapefruit juice: can elevate drug exposure and precipitate hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask reflex tachycardia. - Diuretics: additive antihypertensive effect, monitor electrolytes and volume status. - Other antihypertensive agents: dose adjustments may be needed to avoid excessive blood‑pressure reduction.